Correlation Between Catalyst Pharmaceuticals and Skechers USA

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Catalyst Pharmaceuticals and Skechers USA at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Catalyst Pharmaceuticals and Skechers USA into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Catalyst Pharmaceuticals and Skechers USA, you can compare the effects of market volatilities on Catalyst Pharmaceuticals and Skechers USA and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Catalyst Pharmaceuticals with a short position of Skechers USA. Check out your portfolio center. Please also check ongoing floating volatility patterns of Catalyst Pharmaceuticals and Skechers USA.

Diversification Opportunities for Catalyst Pharmaceuticals and Skechers USA

-0.71
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Catalyst and Skechers is -0.71. Overlapping area represents the amount of risk that can be diversified away by holding Catalyst Pharmaceuticals and Skechers USA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Skechers USA and Catalyst Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Catalyst Pharmaceuticals are associated (or correlated) with Skechers USA. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Skechers USA has no effect on the direction of Catalyst Pharmaceuticals i.e., Catalyst Pharmaceuticals and Skechers USA go up and down completely randomly.

Pair Corralation between Catalyst Pharmaceuticals and Skechers USA

Given the investment horizon of 90 days Catalyst Pharmaceuticals is expected to generate 1.07 times more return on investment than Skechers USA. However, Catalyst Pharmaceuticals is 1.07 times more volatile than Skechers USA. It trades about 0.12 of its potential returns per unit of risk. Skechers USA is currently generating about -0.03 per unit of risk. If you would invest  1,618  in Catalyst Pharmaceuticals on September 1, 2024 and sell it today you would earn a total of  589.00  from holding Catalyst Pharmaceuticals or generate 36.4% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Catalyst Pharmaceuticals  vs.  Skechers USA

 Performance 
       Timeline  
Catalyst Pharmaceuticals 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Catalyst Pharmaceuticals are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating basic indicators, Catalyst Pharmaceuticals may actually be approaching a critical reversion point that can send shares even higher in December 2024.
Skechers USA 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Skechers USA has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong forward-looking signals, Skechers USA is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.

Catalyst Pharmaceuticals and Skechers USA Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Catalyst Pharmaceuticals and Skechers USA

The main advantage of trading using opposite Catalyst Pharmaceuticals and Skechers USA positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Catalyst Pharmaceuticals position performs unexpectedly, Skechers USA can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Skechers USA will offset losses from the drop in Skechers USA's long position.
The idea behind Catalyst Pharmaceuticals and Skechers USA pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.

Other Complementary Tools

Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
FinTech Suite
Use AI to screen and filter profitable investment opportunities
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets